StockpollyBeta
Get App
Popularity #656
BBIO · NASDAQ · Biotechnology

BridgeBio Pharma (BBIO)

Develops and commercializes genetically targeted medicines through a decentralized portfolio model.

$69.31
After hours+0.07 (+0.10%)
At close$69.24(+4.00%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue42211236117111121154195222
Cost of revenue111112347151015
Gross profit31211224114107114139184207
161179210177194230218241259324290314
Research & development125130141115120130111111113142127149
364866606995106129138182164186
General & administrative00000000000186
Other expenses01335511900−21
Operating income−158−1770−176−192−226−104−134−145−185−106−107
−227−3710027−40−65−47−41−12−61−49
Interest income464535546467
Interest expense202023232330423812125313
Other non-operating income1−2713−123−51102310300836
Income before tax−179−170−36−76−164−266−170−182−186−197−167−156
Income tax expense00000102−2000
Net income from continuing operations−179−170−36−76−164−267−170−184−185−197−167−156
Net income−177−168−35−73−162−265−167−182−183−197−164−152
EPS, basic−$1.08−$0.96−$0.20−$0.39−$0.86−$1.40−$0.88−$0.95−$0.96−$1.00−$0.84−$0.78
EPS, diluted−$1.08−$0.96−$0.20−$0.39−$0.86−$1.40−$0.88−$0.95−$0.96−$1.00−$0.84−$0.78
Weighted average shares, basic163174179188189189190191191197195196
Weighted average shares, diluted163174179188189189190191191197195196
EBITDA−158−148−11−51−140−235−126−143−173−180−113−137
Depreciation & amortization222221111516
EBIT−159−150−13−53−141−236−127−144−175−185−114−143